Get started

Cannabis

[CGC] Will be Loadin up Before Next Uptrend CrossThis is now my number two long term growth pick, recently supplanted by the winning APHA/TLRY combo. Still a better company than ACB by a good margin. OGI best value and ACB next best value though, these two been in the trenches for most of 2019 relative to the overall industry. HEXO and SNDL still strugglin but holdin up OK, also great value there but much riskier. CRON has been very quiet but holding at a steady level at least. I'm really loving my IIPR, YCBD and VFF pickups from a few months back too. Kickin myself for missing GRWG, waiting for better value now.
NASDAQ:CGCLong
by ProfitHarvest
4
[ACB] Up Up and AWAY... Really Hopin' for It to Stone Though!Wow ACB is still really undervalued here. Gravity still strong, for good reason too, TLRY/APHA is crushin the game right now with CGC not far behind. Really hopin for this competitive pressure to keep the lid on prices and maybe even drop it back down, most likely value pickup here although there's a lot of great players on the scene right now. CLVR is my new Value Sweatheart... get it while the gettins good. It's about to join the Green Gold Rush here. It's drug dealin though, plenty of room of ACB to thrive although even OGI lookin to take it's place in the rankings. Had a lot of great FOMO runs with this stock, should be plenty more ahead!
ALong
by ProfitHarvest
8
ACB - best Cannabis stock for LONG.What do I expect from $ACB (Aurora Cannabis Inc) this week? ☘️☘️☘️ This big triangle is almost ready for a breakout. He was formed throughout all 2020 so it's a start of a big move.🤑 Today we are on 12.80$ price line - the same price was in Oct 2016. And we did +60% per week: from 12.70$ to 21.85$. ✅We have a bullish cannabis sector. ✅We have a golden cross on D chart. ✅We have a bullish pattern on the chart. I think it's one of the best options on the cannabis market right now. TLRY ( Tilray , Inc. ) ZYNE ( Zynerba Pharmaceuticals Inc ) also looks nice! but I see 🚀INSANE🚀 potential in this/next week in ACB . Thanks.
ALong
by Icemoney666
2
SNDL - LONG (update)(update 1/7/20) - SNDL successfully climbed above our cyan resistance line and is now using it as support. SNDL tested the line as support once and did not break back under it. This gives us confidence that the uptrend momentum can now resume. We are now bullish! Many possibilities exist in the world of technical analysis and ours could play out totally wrong, but we believe the odds are in our favor. If in the case SNDL goes down next week, the cyan line is of course our first major support. A break under that could trigger a sell to roughly $0.85. So keep em tight and ride the ride! - HH
NASDAQ:SNDLLong
by HH_Analysts
2
Bullish news for the cannabis industry.Yesterday’s announcement of a movement towards cannabis legislation has been the best news for the industry since the listing of cannabis stocks. The THCX fund is newer and has a lower market cap then the MJ ETF, it also trades at a lower price making an attractive buy for retail investors. It’s holdings are: APHA Aphria Inc 8.95% 603437 TLRY Tilray Inc 7.83% 333051 CGC Canopy Growth Corp 6.94% 172783 GRW. GROW GENERATION 6.44% 129468 GWPH. GW Pharmaceuticals P 6.16% 32626 VFF Village Farms Intern 5.96% 476411 CRON Cronos Group Inc 5.63% 514377 AMRS Amyris Inc 4.68% 444447 HYFM HYDROFARM 4.67% 62020 Technically speaking, yesterday surge In volume along with positive news is driving the stock higher. If we manage to have a positive close 1/4/21 this could be the start of accumulation, and a move to complete the rounded bottom and test the IPO price, here a cup and handle, or a continuation of the uptrend do to social media, new retail investors, hype, super positive outlook could form. Holding shares
TLong
by Yoimdop3
CURALEAF HOLDINGS TO $25 (CSE)CURALEAF Third Largest Cannabis Company Worldwide FUNDAMENTALS & TECHNICALS 1. February sell off has resided and patterns are looking bullish. We are in line to reach $25 by earnings call on March 22nd (catalyst) 2. January highs have been tested at $16.70. Levels involved with $50 Million Canaccord Genuity offering and the replacement of the CEO 3. Previous quarter report forecasts positive EBITDA 4. Owner Boris Jordan is extremely involved and wants to raise the valuation 5. CURA is the third largest company by revenue. APHRIA- CANOPY GROWTH- CURALEAF. Size of the company does not match the valuation in relation to its peers. This is a $40 Stock with this basis 6. Cannabis Sector is bullish particularly in the US CANNABIS with Biden 7. Company posts solid earnings of $100Million+ and has licenses on numerous states and keeps acquiring them 8. Momentum Squeeze has indicated a shift of direction 9. Divergence Oscillator is centered and with room for a bull push (7hr Chart) ALL SUCCESS This publishing is for research purposes and in no way represents an order, directive or suggestion. This is for informational purposes and represents and opinion. Everyone is responsible for their own decisions and should invest only within their means as a sovereign individual GREAT APPRECIATION AND THANK YOU to the Indicator Publishers: CRYPTOFUNDMANAGER & LAZYBEAR CSE:CURA
C
by MGNCAPITALMARKETS